Clinical Trial Update: A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update indicates ongoing Phase 2/Phase 3 studies evaluating microbiota transplantation to treat acute lung injury caused by sepsis (ARDS/ALI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome
• Sepsis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI) | Phase 2, Phase 3 | Status: RECRUITING